|
SATL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.881800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.931600E-02 |
| Normal-vs-Stage2 |
5.636000E-01 |
| Normal-vs-Stage3 |
5.666500E-02 |
| Normal-vs-Stage4 |
2.558200E-02 |
| Stage1-vs-Stage2 |
3.167600E-02 |
| Stage1-vs-Stage3 |
7.586400E-01 |
| Stage1-vs-Stage4 |
4.290600E-01 |
| Stage2-vs-Stage3 |
1.988430E-02 |
| Stage2-vs-Stage4 |
1.623590E-02 |
| Stage3-vs-Stage4 |
6.427000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.520000E-03 |
| Normal-vs-AfricanAmerican |
3.473800E-01 |
| Normal-vs-Asian |
4.170000E-02 |
| Caucasian-vs-AfricanAmerican |
2.324800E-03 |
| Caucasian-vs-Asian |
9.676600E-01 |
| AfricanAmerican-vs-Asian |
1.127750E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.575700E-02 |
| Normal-vs-Female |
8.163500E-02 |
| Male-vs-Female |
7.985200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.604300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.081400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.377400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.087800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.361000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.240980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.460200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.810400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.882600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.118000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.545600E-02 |
| Classical-VS-Follicular |
1.954180E-02 |
| Classical-VS-Other |
4.891200E-01 |
| Classical-VS-Normal |
4.748300E-02 |
| Tall-VS-Follicular |
9.381200E-04 |
| Tall-VS-Other |
7.755600E-01 |
| Tall-VS-Normal |
3.383900E-03 |
| Follicular-VS-Other |
1.929770E-01 |
| Follicular-VS-Normal |
8.943400E-01 |
| Other-VS-Normal |
1.678170E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.338800E-01 |
| Normal-vs-N1 |
2.750400E-04 |
| N0-vs-N1 |
9.637400E-04 |
|
|
